Semaglutide's hidden role: calming inflammation after a blood clot?
NCT ID NCT06118203
First seen Apr 02, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study looked at whether semaglutide, a diabetes drug, can reduce inflammation in people who recently had a pulmonary embolism (a blood clot in the lung). Researchers measured specific blood markers before and after 4 weeks of treatment in 18 participants. The goal was to understand how the drug might affect the body's response, not to treat the clot itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Colm McCabe
London, SW3 6NP, United Kingdom
Conditions
Explore the condition pages connected to this study.